chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the 9th day after my first Moderna shot I noticed a rash of three red spots on my injection arm that looked similar to bug bites. the next day, more of the area turned red. on the 11th day, the area was itchy and somewhat swollen and the red was expanding. Today, the 13th day, I woke up feeling slightly nauseous.
Redness, swelling, itching, warmth, pain in right thigh. Worsening, seen in HD 5/10/06 in morning. Presented to ER in evening.
injection site redness; injection site warmth; injection site swelling; Pain; injection site pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 23JK5, expiry date 13th April 2020) and (batch number 2792L, expiry date 21st September 2021) for prophylaxis.   On 15th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, the dose was an unknown dose. On 15th May 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On 16th May 2019, the patient experienced erythema of extremities, skin warm, swelling arm and pain. On an unknown date, the outcome of the pain in arm, erythema of extremities, skin warm, swelling arm and pain were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, erythema of extremities, skin warm, swelling arm and pain to be related to Shingrix.  Additional details were reported as follows: The pharmacist reported that the patient experienced redness, warmth, pain, and swelling approximately 2.5 inches below injection site. The health care professional reported that the arm pain began the night Shingrix was received, pain, swelling, warmth, and redness began the next morning.  The health care professional reported that the events had improved since they began, but not have not resolved.
fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Right arm ached around to back shoulder blade and to front to breast area.  Pain radiated in the back of neck, chest felt heavy with no problems with breathing.
SUBCLAVICAL LYMPH NODE SWELLING ON THE LEFT SIDE; RAISE AND TENDER ON THE RIDGE OF JAW; TENDER ON THE NECK WHEN PRESSED HURTS; LITTLE BIT WARM SWELLING ON THE RIDGE OF JAW; WARM SWELLING ON THE NECK; FATIGUE; BODY ACHES; FEVER OVER 101 DEGREES; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 07-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-JUN-2021, the subject experienced body aches. On 07-JUN-2021, the subject experienced fever over 101 degrees. Laboratory data included: Body temperature (NR: not provided) Over 101 degrees. On 08-JUN-2021, the subject experienced subclavical lymph node swelling on the left side. On 08-JUN-2021, the subject experienced raise and tender on the ridge of jaw. On 08-JUN-2021, the subject experienced tender on the neck when pressed hurts. On 08-JUN-2021, the subject experienced little bit warm swelling on the ridge of jaw. On 08-JUN-2021, the subject experienced warm swelling on the neck. On 08-JUN-2021, the subject experienced fatigue. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches on 09-JUN-2021, and fever over 101 degrees on 08-JUN-2021, and had not recovered from subclavical lymph node swelling on the left side, raise and tender on the ridge of jaw, fatigue, tender on the neck when pressed hurts, little bit warm swelling on the ridge of jaw, and warm swelling on the neck. This report was non-serious.
Approximately 10 mins. after receiving vaccine, the patient started c/o feeling warm and cold at the same time, headache, dizziness, confusion and hands feeling heavy. Patient stated that he is allergic to Benadryl. Assessment: Person was alert and responsive to questioning. Patient denied of mouth and neck swelling. None noted. Patient denied of SOB or trouble breathing. Noted facial redness and perfused sweating. Nail-beds pink, resp. 24 with deep breathing off/on. Trembling noted while checking pulse 92. Manual fan blown in face. 911 notified. Ambulance arrived 10:45 am. B/P 142/90, P 104 and O2 Sat 99 %.  Patient continue to c/o confusion and hands feeling heavy.  Patient called wife on cell phone with a little difficulty in dialing cell phone. Wife spoke with patient and also EMT. Decision was made per patient and wife that he should go to the ER for evaluation. 11:20 am Patient was transported per stretcher to Hospital per ambulance for evaluation. 10:55 am Arrived at hospital per ambulance.  Assessment started per CRNP with IV (NS bolus-1000 ml), Radiology (ECG Tracing/EKG) and Labs (BMP; CBC with Diff./Creatine Kinase/Troponin T).  All procedures and labs within normal range. Discharged 04/01/2021 1:54 pm with diagnosis of Dizzy and Near Syncope.
Pfizer pediatric dose was administered to child at 4 years and 5 months of age. No adverse reaction.
I tested positive (via PCR test) for COVID on 09/03/2021. I received my dose 3 on 09/16/2021. I started having with GI symptoms, chronic fatigue, joint pain, anemic and memory issues. I have IBS with severe constipation and osteoarthritis. New drugs: Linzess and prednisone. I've had steriod injections too.
2/5/21 - arm hurt 2/6/21 - threw up almost every hour on the hour 2/7/21 - body aches all day 2/8/21 - exhaustion 2/9/21 - exhaustion ever since 2/9 exhaustion and as of 2/16/21 feeling dizzy
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; VERY VERY LITTLE PAIN IN THE INJECTION SITE; This spontaneous report received from a patient concerned a 66 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's past medical history included cardiac arrhythmia, and concurrent conditions included migraine headache, non-alcohol user, and non-smoker. The patient experienced drug allergy when treated with morphine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, and expiry: unknown) dose was not reported, 1 total administered to left arm on 10-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in JUN-2021, the patient experienced very little pain in the injection site. The shot never got hard or warm. Patient had no fever, no dizziness, no runny nose. Patient did the antibody test and on 31-Jul-2021 negative antibody result was found (confirmed immunological vaccine failure). Patient was not feeling protected. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the very very little pain in the injection site and confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210804980-Covid-19 vaccine ad26.cov2.s-Confirmed immunological vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
face went numb and a lymph node under my tongue was sore and swollen for an hour
This prospective pregnancy case was reported by a consumer (also the subject) and described the occurrence of vaccine exposure during pregnancy in a 41-year-old female subject who was vaccinated with Influenza vaccine (manufacturer unspecified) during pregnancy. A physician or other health care professional has not verified this report. Concurrent medications included Prenatal vitamin. On 23 November 2011 at 18:30 the subject received a dose of Influenza vaccine (manufacturer unknown, unknown route, right arm) and experienced vaccine exposure during the second trimester of her pregnancy. The estimated delivery date was 5 May 2012. Gestational age at the time of vaccination and date of last menstrual period were not provided. Follow up received from the subject on 09 February 2012. The subject provided authorization to contact her physician. She reported the lot number indicating that she had received FLUARIX. She also noted that she had no reaction to the vaccination. Follow up received from the subject's physician on 13 March 2012. Concurrent medical conditions included advanced maternal age and declined amniocentesis. Sickle trait with father of the baby (FOB) same and declined amniocentesis, PPD skin test positive and chest x-ray negative indicating latent tuberculosis infection (LTBI), varicella non-immune and suboptimal cardiac imaging with multiple ultrasounds. The subject's physician reported that the pregnancy was by normal contraception and no in-vitro fertilization was used. The subject is pregnant with one fetus. The date of the last menstrual period was 20 July 2011. The gestational age at the time of the FLUARIX was 16 weeks. The subject received the FLUARIX 0.5 ml dose by intramuscular injection. On 21 December 2011, the subject received Tdap from an unknown manufacturer 0.5 ml dose by intramuscular injection. The gestational age at the time of the Tdap was 21 weeks. The vaccine exposure during pregnancy with Tdap was also during the second trimester. On an unknown date, less than a year after vaccination with FLUARIX and Tdap, the subject experienced abnormal quad screen indicating increased risk for open neural tube defect (ONTD) and declined amniocentesis, elevated glucose loading test (GLT) with glucose tolerance test (GTT) pending and anemia minor. However, the physician also noted, the subject had not experienced any adverse events.
Flu like symptoms 4 days. Those disappeared. On day 2 after injection my elect eye became itchy, very painful, and red. It never got better. Then on day 12 I lost vision in that eye. Still painful. I continue to have half tunnel vision and pain.
weekend of 19FEB93 pt states had redness throughout body,joint & back pain,high fever,knots behind ears;pain was so severe crawled to bathroom;22FEB93 limping @ work;over next 2yrs pt devel chronic arthritis & neuro problems;poss cushing
Pharmacist administered pneumovax in patient's left deltoid on 8/30/21 around 3:30PM.  Within 5 minutes, patient was complaining of severe lower back pain, which he described as "hot" and "firey."  Pharmacist escorted him to a seat and provided him with an ice pack.  She asked if he had any other symptoms including shortness of breath, trouble breathing, pain at the injection site, itchiness, and arm pain; Patient said he had no other symptoms.  Pharmacist examined the injection site and observed no discoloration (including redness), no inflammation, and confirmed the area was not hot to touch.  Pharmacist asked the patient if he had any history of reactions from vaccines, history of back pain or history of nerve pain. Patient said he had no history of reaction post-vaccination,  no history of back pain, but he mentioned he's had recent nerve pain that he just got medication for. Patient said he had been on gabapentin for 1 day prior to this vaccination. Pharmacist had the patient sit for observation.  Within 10-15 minutes, Patient said he started to feel a bit better, and felt well enough to go home.  Once Patient got home (roughly 30 minutes later), he called Pharmacist and let him know that he was feeling much better.  Pharmacist let him know she would be reaching out to his pain management doctor and following up with him over the next couple weeks.  She left a message with the doctor's office that evening, and followed up with the office the next morning (8/31/21) around 9:00AM.  Pharmacist spoke to staff at Doctor's office asking to speak with Doctor.  Staff stated that Doctor spoke with Patient earlier that morning, and that Doctor does not accept phone calls; he declined speaking with Pharmacist. Pharmacist left a message on Patient's voicemail on 8/31/21 at 11:57AM to see how he was feeling and ask if he was going to seek medical care.
Myalgia, Arthralgia, NauseaVomiting, Fatigue, Chills, pain at injection Narrative:  1/13 Was seen in Employee Health, sent home. No fever.
2 hours after vaccine patient developed hives on legs.  24 hours after vaccine patient developed hives on hands.
Admission Date: 11/30/2022 Discharge Date: 12/11/2022  COVID positive date 11/30/2022   PRESENTING PROBLEM: Weakness COVID-19   HOSPITAL COURSE: 94yom with pmhx CVA, HTN, mild cog   CONSULTS / RECOMMENDATION: N/a   INPATIENT PROCEDURES: N/a   BP 142/67  | Pulse 77  | Temp 36.3 °C (Oral)  | Resp 20  | Ht 1.727 m  | Wt 93.8 kg  | SpO2 95%  | BMI 31.44 kg/m²    Physical Exam Vitals and nursing note reviewed.  Constitutional:      General: He is not in acute distress.    Appearance: He is obese.  HENT:     Head: Normocephalic and atraumatic.     Nose: No congestion.     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear.  Eyes:     Extraocular Movements: Extraocular movements intact.     Pupils: Pupils are equal, round, and reactive to light.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.     Breath sounds: Normal breath sounds.  Abdominal:     General: Abdomen is flat. Bowel sounds are normal. There is no distension.     Palpations: Abdomen is soft.  Musculoskeletal:        General: No swelling or deformity. Normal range of motion.     Cervical back: Normal range of motion and neck supple.     Right lower leg: No edema.     Left lower leg: No edema.  Skin:    General: Skin is warm and dry.     Capillary Refill: Capillary refill takes less than 2 seconds.  Neurological:     General: No focal deficit present.     Mental Status: He is alert and oriented to person, place, and time.     Cranial Nerves: No cranial nerve deficit.     Motor: Weakness present.  Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal.
Redness in left arm over deltoid, swollen and warm, both vaccinations in same arm. Rocephin, Prednisone, Benadryl, Keflex.
Sore arm; A spontaneous report was received from a Consumer concerning a  58 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced event Arthralgia.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 6-feb-2021prior to the onset of the events, the patient received their first planned dose of mRNA-1273. The lot no. and location of vaccination injected is unknown  Laboratory details was not provided.  No treatment information was provided. asked can she take antibiotics for other problem.  Action taken with mRNA-1273 in response to the events was not reported.    The event sore arm outcome is unknown  The reporter assessed the event Sore arm as  related to study drug.
Fever >102-104F, vomiting, diarrhea.  Acetaminophen.
A few days after i received vaccine I had severe bruising on both of ny knees AND elbows.  The  bruises were the size of if tea saucers and were EXTREMELY PAINFUL.   I have since had extreme pain and loss of ability to lift anything (more than a pound) in my right elbow  About a week and a 1/2 after I received  the vaccine my fingers and both hands began to have numbness.  It has since moved up in between my thumbs and 4 fingers and to the tops of my hands.
Pt presented 13 days s/p vaccination of MMR, TDaP & Varicella w/ rubella type rash; pink macular papular rash involving face, UE's & torso; Pt also w/ low grade fever (subjective).  Symptoms started last PM.  Tx'd w/ benadryl, zyrtec & tylenol only at this point.  Expect resolution in the next 3-4 days.
Hospital Course This is a 60M with PMHx of DM on Dialysis MWF, HTN who was admitted to AHSJH-E for Covid 19 pneumonia. In the ED, Patient was hypertensive.  CXR Patchy alveolar opacities are present bilaterally, right greater than left. He was initially on room air, but then became hypoxic. ID was consulted and patient was started on decadron. His onset of symptoms was too late for remdesivir therapy. He was weaned down to room. Patient is an ESRD patient on dialysis and was seen by Nephrology and recevied his usual scheduled dialysis while in the hospital. His blood pressure was initially very uncontrolled since he was in the ER. His home medications were resumed and amlodipine was started and increased to 10mg with noted improvement to his BP of 160/170 on the day of discharge which was acceptable per Nephrology. Patient had a scheduled outpatient fistulogram and was still here in the hospital and underwent the procedure on day of discharge with noted success. He was placed on plavix and aspirin by vascular surgeon. Patient had no complaints on day of discharge and remained medically stable. All other chronic conditions remained stable and no further interventions warranted.
Swelling of injection site, red hot skin, difficulty taking deep breathes, fatigue, headache. Took over the counter ibuprophen and claritan Better after 3 days but anti histamine made me nauseous after 2 doses.
PAIN AND WEAKNESS AT INJECTION SITE SINCE VACCINE ADMINISTRATION ON 10/14/2008
Fever elevated to 103-104 a few hours after PCV, Comvax, and IPV administered.
Redness started 12/6. Came back to clinic 1:30pm 12/7. Right lateral upper 1/2 of upper leg indurated-deep pink-13cm circle-warm to touch.
No additional AEs were reported.  No further information provided.; Medical assistant reported that a 12 month old patient received both PROQUAD and VARIVAX on 10/12/2022.; This spontaneous report has been received from a medical assistant, concerning a 12-months-old female patient. The patient's medical history, other concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided.  On 12-OCT-2022, the patient was vaccinated with measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (recombinant Human albumin) (PROQUAD) (lot number w024552 has been verified to be valid; expiration date reported and established as 31-JAN-2024) and varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number w012164 has been verified to be valid; expiration date reported and established as 12-APR-024) (accidental overdose), as prophylaxis, diluted with sterile diluent (doses, vaccination scheme, and routes of administration were not provided).
Body aches, headache, chills, sweating, fever, extreme fatigue (Shot on Friday, began on Monday evening)  About 6 days after the shot (Wednesday) I had the chills, a slight fever (99.1) and was so fatigued I slept for 20 hours straight, woke up for about 3 hours and then slept for an additional 10 hours.  I had the chills and sweats so bad that the sheets and mattress were soaked when I woke up.
Received immunization 3/8/2014: Flare of guttate psoriasis. Initially with local rxn (possibly vesicular at site of shingles vaccine but has subsequently over past 4 months had same guttate psoriasis. (Locations: Both arms/lower back, scalp, b/l thighs.
went down; she was dehydrated; ended up giving the full dose instead of the half dose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (went down), DEHYDRATION (she was dehydrated) and ACCIDENTAL OVERDOSE (ended up giving the full dose instead of the half dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (ended up giving the full dose instead of the half dose). On an unknown date, the patient experienced MALAISE (went down) and DEHYDRATION (she was dehydrated). On 22-Oct-2021, ACCIDENTAL OVERDOSE (ended up giving the full dose instead of the half dose) had resolved. At the time of the report, MALAISE (went down) and DEHYDRATION (she was dehydrated) outcome was unknown.            No concomitant medication was reported.  No treatment drug was reported.   This case was linked to MOD-2021-366021 (Patient Link).
Extreme pain in joints of fingers, wrists, ankles, toes,        All symptoms lasting until 6/18/21 and continuing with some pain in joints and Extreme Bone Pain in arm/legs                                                                             tiredness Extreme muscle pain in most of body Extreme fatigue necessitating sleep during the day brain fog
Case number PHEH2014US018221 is an initial spontaneous report from the health care professional (medical assistant) received on 09 Sep 2014. This report refers to a 11 year old male patient. He was vaccinated with MENVEO (batch number: not reported) at a dose of 0.5 ml intramuscularly on 02 Sep 2014. It was reported that the vaccine received by the patient had been stored at 47 F for 10 minutes before administration to the patient. No adverse event reported following this medication error (incorrect storage of drug).
He is not able to use the bathroom, he is feeling really  bloated and cramps in the stomach; he says he feels full; He is not able to use the bathroom, he is feeling really  bloated and cramps in the stomach; he says he feels full; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. A male patient received BNT162b2 (BNT162B2), administration date 06Jan2022 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL DISTENSION (non-serious), ABDOMINAL PAIN UPPER (non-serious) all with onset 07Jan2022, outcome "unknown" and all described as "He is not able to use the bathroom, he is feeling really  bloated and cramps in the stomach; he says he feels full". Additional information: The patient took the Pfizer vaccine and he was not able to use the bathroom, feeling really  bloated and cramps in the stomach. The patient wanted to go to the bathroom but when he went he couldn't do anything and the stomach was cramping like he said he felt full. He got it yesterday and he got the vaccine a day before.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Redness and warmth (6 cm diameter) to (L) deltoid at injection site.
Developed fever of 101.3 degrees 3 hours after flu vaccine given. Treated with acetaminophen liquid and cooling measures.